| Date Filed | Type | Description |
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/15/2023 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 611,000 shares
@ $211.4522, valued at
$129.2M
Sold 313,400 shares
@ $128.4335, valued at
$40.3M
Sold 273,728 shares
@ $207.7171, valued at
$56.9M
|
|
| 06/12/2023 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,163,825 shares
@ $218.1443, valued at
$253.9M
Sold 213,700 shares
@ $130.3523, valued at
$27.9M
Sold 328,952 shares
@ $217.0183, valued at
$71.4M
Sold 281,400 shares
@ $130.8322, valued at
$36.8M
Sold 968,812 shares
@ $213.9125, valued at
$207.2M
|
|
| 05/15/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2023 |
SC 13G/A
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. reports a 5.9% stake in Legend Biotech Corporation |
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/24/2022 |
4
| HHLR ADVISORS, LTD. (10% Owner) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Acquired 7,800 shares
@ $0 |
|
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. reports a 7.6% stake in Enfusion, Inc. |
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2022 |
SC 13G
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. reports a 6.9% stake in TScan Therapeutics, Inc. |
| 11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 10/27/2021 |
4
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. (10% Owner) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 647,862 shares
@ $15.895, valued at
$10.3M
|
|
| 10/21/2021 |
3
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. (10% Owner) has filed a Form 3 on Enfusion, Inc. |
| 08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/19/2021 |
SC 13D/A
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. reports a 0% stake in Enstar Group Limited |
| 07/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/16/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/14/2020 |
3
| HILLHOUSE CAPITAL ADVISORS, LTD. (10% Owner) has filed a Form 3 on BeiGene, Ltd. |
| 05/15/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2020 |
SC 13G
| Hillhouse Capital Management, Ltd. reports a 9.1% stake in Zoom Video Communications, Inc. |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Management, Ltd. reports a 2.3% stake in Sea Limited |
| 02/14/2020 |
SC 13G/A
| Hillhouse Capital Management, Ltd. reports a 0% stake in NIO Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|